In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Bone Level

Many adults have one or more missing teeth. The negative consequences of partial or total edentulousness are numerous in the orofacial sphere:

• Edentulousness causes a strong aesthetic deficit due to the lack of support of facial tissues and musculature;
• Edentulousness generates a functional deficit that can have significant repercussions on the nutritional status of the affected subject;
• Edentulousness is accompanied by bone resorption of the jawbones which is inevitable in the absence of implant treatment;
• In addition, the resulting feelings of discomfort and fragility are experienced as a real psychological handicap by the patient, partially or totally edentulous, which can then have significant repercussions on his social life.

TBR® Bone Level implants are intended for placement in the maxillary or mandibular arch in partially or completely edentulous patients for prosthetic restoration in the following cases:

• Single edentulousness,
• Intercalary edentulousness,
• Terminal edentulousness,
• Total edentulousness.

The following clinical conditions must be observed before placing a dental implant:

• Sufficient quality and volume of bone support;
• Healthy oral condition;
• no contraindications for implant setting

The expected benefits of this surgery are to improve the quality of life of patients, to recover the chewing function and the aesthetics of the smile.

Inclusion criteria

• Patient 18 years of age or older
• Patient who has completed bone growth
• Patient informed and willing to participate in the study
• Partially or totally toothless patient who will be implanted with the TBR® Bone Level implant(s) for the prospective cohort
• Patient implanted with the TBR® Bone Level implant(s) before June 2011 for the retrospective cohort

Exclusion criteria

• Pregnant or lactating women
• Patient with bone disease of the head and neck region
• Patient refusing to participate in the study
• Patient with at least one contraindication to implantation
• Patient on osteoporosis treatment with Biphosphonates or Denosumab.